JPS61100522A - 抗腫瘍性血液製剤の製造法 - Google Patents

抗腫瘍性血液製剤の製造法

Info

Publication number
JPS61100522A
JPS61100522A JP59221978A JP22197884A JPS61100522A JP S61100522 A JPS61100522 A JP S61100522A JP 59221978 A JP59221978 A JP 59221978A JP 22197884 A JP22197884 A JP 22197884A JP S61100522 A JPS61100522 A JP S61100522A
Authority
JP
Japan
Prior art keywords
blood
lipopolysaccharide
immobilized
gram
ribopolysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59221978A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0533688B2 (fr
Inventor
Masatomo Kodama
小玉　正智
Toru Tani
徹 谷
Shiro Saikai
西海　四郎
Jiro Suzuki
鈴木　慈郎
Kazuo Teramoto
和雄 寺本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP59221978A priority Critical patent/JPS61100522A/ja
Publication of JPS61100522A publication Critical patent/JPS61100522A/ja
Publication of JPH0533688B2 publication Critical patent/JPH0533688B2/ja
Granted legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP59221978A 1984-10-24 1984-10-24 抗腫瘍性血液製剤の製造法 Granted JPS61100522A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59221978A JPS61100522A (ja) 1984-10-24 1984-10-24 抗腫瘍性血液製剤の製造法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59221978A JPS61100522A (ja) 1984-10-24 1984-10-24 抗腫瘍性血液製剤の製造法

Publications (2)

Publication Number Publication Date
JPS61100522A true JPS61100522A (ja) 1986-05-19
JPH0533688B2 JPH0533688B2 (fr) 1993-05-20

Family

ID=16775151

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59221978A Granted JPS61100522A (ja) 1984-10-24 1984-10-24 抗腫瘍性血液製剤の製造法

Country Status (1)

Country Link
JP (1) JPS61100522A (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096275A1 (fr) * 2003-04-28 2004-11-11 Sekisui Chemical Co., Ltd. Instrument d'induction de cytokine et procede d'induction correspondant
WO2004096247A1 (fr) * 2003-04-28 2004-11-11 Sekisui Chemical Co., Ltd. Instrument d'induction de cytokine et procede d'induction correspondant
JP2009132728A (ja) * 1995-06-07 2009-06-18 Cerus Corp 血液製剤からソラレンを除去するための方法およびデバイス
US10688129B2 (en) 2013-11-26 2020-06-23 Central Biomedia, Inc. Method of producing a designer blood product, method of using a designer blood product, and diet for selectively enhancing blood profile

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009132728A (ja) * 1995-06-07 2009-06-18 Cerus Corp 血液製剤からソラレンを除去するための方法およびデバイス
WO2004096275A1 (fr) * 2003-04-28 2004-11-11 Sekisui Chemical Co., Ltd. Instrument d'induction de cytokine et procede d'induction correspondant
WO2004096247A1 (fr) * 2003-04-28 2004-11-11 Sekisui Chemical Co., Ltd. Instrument d'induction de cytokine et procede d'induction correspondant
US10688129B2 (en) 2013-11-26 2020-06-23 Central Biomedia, Inc. Method of producing a designer blood product, method of using a designer blood product, and diet for selectively enhancing blood profile
US11419893B2 (en) 2013-11-26 2022-08-23 Central Biomedia, Inc. Method of producing a designer blood product, method of using a designer blood product, and diet for selectively enhancing blood profile

Also Published As

Publication number Publication date
JPH0533688B2 (fr) 1993-05-20

Similar Documents

Publication Publication Date Title
Aso et al. Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, an organic germanium compound
Allison et al. Effects of endotoxin on macrophages and other lymphoreticular cells
JPH05503952A (ja) 可溶性グルカン類の製造方法
JP2001509778A (ja) 移植片不全または対宿主性移植片病を伴わない同種異系造血幹細胞移植法
JPH08500623A (ja) 新規グルカン調製物
JPH0749052B2 (ja) エンドトキシン中和剤
Hasegawa et al. Accelerated restoration of the leukocyte number and augmented resistance against Eschericia coli in cyclophosphamide-treated rats orally administered with a hot water extract of Chlorella vulgaris
Lindberg et al. Cellular immunity to toxoplasma and besnoitia in hamsters: specificity and the effects of cortisol
US5298243A (en) Colony stimulating factor-gelatin conjugate
JPS61100522A (ja) 抗腫瘍性血液製剤の製造法
US5171738A (en) Method of treating malignant tumors
WO1989009619A1 (fr) Procede et moyen permettant un traitement immunostimulateur du sang avec un mitogene
EP0107119B1 (fr) Matériau pour le traitement du sang
Gordon et al. Protein A-independent tumoricidal responses in dogs after extracorporeal perfusion of plasma over Staphylococcus aureus
Larner Redistribution of mixed lymphocyte culturereactive cells after antigen administration
JPH0742233B2 (ja) 血液処理剤
Almdahl et al. Protection by aminated glucan in experimental endogenous peritonitis
US4772469A (en) Production of lymphoid tissue effector cells reactive against cancer cells by means of MER, and use thereof in cancer therapy
JPH0472808B2 (fr)
Cantrell et al. Efficacy of tumor cell extracts in immunotherapy of murine EL-4 leukemia
Alexander Some immunologically based reactions that can cause the regression of large tumor masses
Xu et al. Enhanced susceptibility of target KMT-17 cells to activated macrophages by treatment with the antitumor agent bleomycin
JP2901614B2 (ja) 単糖類および／またはその単糖類を有する糖結合体を含む感染症の予防・治療剤
JPH0364153B2 (fr)
Dupuy et al. Transfer of skin homograft immunity with a plasma factor